{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:12:48Z","timestamp":1787170368810,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HL144727-01A1"],"award-info":[{"award-number":["1R01HL144727-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R56HL134736-01A1"],"award-info":[{"award-number":["1R56HL134736-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL145420"],"award-info":[{"award-number":["HL145420"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["I01CX001892"],"award-info":[{"award-number":["I01CX001892"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL128661"],"award-info":[{"award-number":["R01HL128661"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL148727"],"award-info":[{"award-number":["R01HL148727"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1I01BX002042"],"award-info":[{"award-number":["1I01BX002042"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016421","name":"Cardiovascular Medical Research and Education Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017757","name":"Boston Biomedical Innovation Center","doi-asserted-by":"publisher","award":["R01HL152724"],"award-info":[{"award-number":["R01HL152724"]}],"id":[{"id":"10.13039\/100017757","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017757","name":"Boston Biomedical Innovation Center","doi-asserted-by":"publisher","award":["R33HL142539"],"award-info":[{"award-number":["R33HL142539"]}],"id":[{"id":"10.13039\/100017757","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.chest.2020.09.258","type":"journal-article","created":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T01:32:45Z","timestamp":1601861565000},"page":"1586-1597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Renin-Angiotensin-Aldosterone System Inhibitor Use and Mortality in Pulmonary Hypertension"],"prefix":"10.1016","volume":"159","author":[{"given":"Tim","family":"Lahm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E.","family":"Bar\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Maddox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Plomondon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roham T.","family":"Zamanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.chest.2020.09.258_bib1","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2020.09.258_bib2","doi-asserted-by":"crossref","first-page":"1801900","DOI":"10.1183\/13993003.01900-2018","article-title":"Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update","volume":"53","author":"Vonk Noordegraaf","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2020.09.258_bib3","doi-asserted-by":"crossref","first-page":"1801897","DOI":"10.1183\/13993003.01897-2018","article-title":"Pulmonary hypertension due to left heart disease","volume":"53","author":"Vachiery","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2020.09.258_bib4","doi-asserted-by":"crossref","first-page":"1801914","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary hypertension in chronic lung disease and hypoxia","volume":"53","author":"Nathan","year":"2019","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2020.09.258_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.chest.2020.09.258_bib6","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.healun.2017.02.016","article-title":"The Giessen Pulmonary Hypertension Registry: survival in pulmonary hypertension subgroups","volume":"36","author":"Gall","year":"2017","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"12","key":"10.1016\/j.chest.2020.09.258_bib7","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1164\/rccm.201701-0150WS","article-title":"Enhancing insights into pulmonary vascular disease through a precision medicine approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop report","volume":"195","author":"Newman","year":"2017","journal-title":"Am J Resp Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2020.09.258_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1164\/rccm.201710-2093PP","article-title":"Challenges in pulmonary hypertension: controversies in treating the tip of the iceberg","volume":"198","author":"Elinoff","year":"2018","journal-title":"Am J Resp Crit Care Med"},{"issue":"16","key":"10.1016\/j.chest.2020.09.258_bib9","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.chest.2020.09.258_bib10","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.chest.2020.09.258_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1164\/rccm.201209-1663PP","article-title":"Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?","volume":"187","author":"de Man","year":"2013","journal-title":"Am J Resp Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2020.09.258_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1086\/675984","article-title":"The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series)","volume":"4","author":"Maron","year":"2014","journal-title":"Pulm Circ"},{"issue":"23","key":"10.1016\/j.chest.2020.09.258_bib13","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1161\/CIRCULATIONAHA.114.006980","article-title":"Emerging concepts in the molecular basis of pulmonary arterial hypertension: part ii: neurohormonal signaling contributes to the pulmonary vascular and right ventricular pathophenotype of pulmonary arterial hypertension","volume":"131","author":"Maron","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.chest.2020.09.258_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12931-017-0679-6","article-title":"Autonomic nervous system involvement in pulmonary arterial hypertension","volume":"18","author":"Vaillancourt","year":"2017","journal-title":"Resp Res"},{"issue":"8","key":"10.1016\/j.chest.2020.09.258_bib15","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1164\/rccm.201203-0411OC","article-title":"Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension","volume":"186","author":"de Man","year":"2012","journal-title":"Am J Resp Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2020.09.258_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jacbts.2016.09.007","article-title":"Renal denervation reduces pulmonary vascular remodeling and right ventricular diastolic stiffness in experimental pulmonary hypertension","volume":"2","author":"da Silva Goncalves Bos","year":"2017","journal-title":"JACC Basic Transl Sci"},{"issue":"8","key":"10.1016\/j.chest.2020.09.258_bib17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/CIRCULATIONAHA.112.094722","article-title":"Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension","volume":"126","author":"Maron","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.chest.2020.09.258_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/eurjhf\/hfs173","article-title":"Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study","volume":"15","author":"Maron","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.chest.2020.09.258_bib19","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.amjcard.2013.04.051","article-title":"Effectiveness of spironolactone plus ambrisentan for treatment of pulmonary arterial hypertension (from the [ARIES] study 1 and 2 trials)","volume":"112","author":"Maron","year":"2013","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.chest.2020.09.258_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/CIRCULATIONAHA.113.007690","article-title":"Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis","volume":"130","author":"Maron","year":"2014","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.chest.2020.09.258_bib21","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1096\/fj.201500042","article-title":"Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension","volume":"30","author":"Aghamohammadzadeh","year":"2016","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.chest.2020.09.258_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12890-018-0604-x","article-title":"Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension","volume":"18","author":"Boehm","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"445","key":"10.1016\/j.chest.2020.09.258_bib23","doi-asserted-by":"crossref","first-page":"eaap7294","DOI":"10.1126\/scitranslmed.aap7294","article-title":"NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension","volume":"10","author":"Samokhin","year":"2018","journal-title":"Science Transl Med"},{"issue":"2","key":"10.1016\/j.chest.2020.09.258_bib24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jacc.2016.10.047","article-title":"The relationship between the right ventricle and its load in pulmonary hypertension","volume":"69","author":"Vonk Noordegraaf","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25 suppl","key":"10.1016\/j.chest.2020.09.258_bib25","doi-asserted-by":"crossref","first-page":"D22","DOI":"10.1016\/j.jacc.2013.10.027","article-title":"Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology","volume":"62","author":"Vonk-Noordegraaf","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.chest.2020.09.258_bib26","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2011.06.068","article-title":"Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy","volume":"58","author":"van de Veerdonk","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.chest.2020.09.258_bib27","doi-asserted-by":"crossref","first-page":"1701886","DOI":"10.1183\/13993003.01886-2017","article-title":"Macitentan in pulmonary hypertension due to left ventricular dysfunction","volume":"51","author":"Vachiery","year":"2018","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2020.09.258_bib28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jchf.2017.02.021","article-title":"Long-Term effect of endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with severe chronic heart failure: primary results of the ENABLE Trials","volume":"5","author":"Packer","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.chest.2020.09.258_bib29","doi-asserted-by":"crossref","unstructured":"Blanco I, Gimeno E, Munoz PA, et\u00a0al. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Resp Crit Care Med.181(3):270-278.","DOI":"10.1164\/rccm.200907-0988OC"},{"issue":"3","key":"10.1016\/j.chest.2020.09.258_bib30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1183\/09031936.00011308","article-title":"A\u00a0randomised, controlled trial of bosentan in severe COPD","volume":"32","author":"Stolz","year":"2008","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.chest.2020.09.258_bib31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-158-9-201305070-00003","article-title":"Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial","volume":"158","author":"Raghu","year":"2013","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.chest.2020.09.258_bib32","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1513\/AnnalsATS.201710-762OC","article-title":"Phosphodiesterase-5-inhibitor therapy for pulmonary hypertension in the US: actual vs\u00a0recommended use","volume":"15","author":"Kim","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.chest.2020.09.258_bib33","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.healun.2015.10.019","article-title":"Elevated pulmonary arterial and systemic plasma aldosterone levels associate with impaired cardiac reserve capacity during exercise in left ventricular systolic heart failure patients: a pilot study","volume":"35","author":"Maron","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.chest.2020.09.258_bib34","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1164\/ajrccm\/136.4.862","article-title":"The effects of angiotensin-converting enzyme inhibition on sodium handling in patients with advanced chronic obstructive pulmonary disease","volume":"136","author":"Farber","year":"1987","journal-title":"Am Rev Resp Dis"},{"issue":"4","key":"10.1016\/j.chest.2020.09.258_bib35","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1164\/ajrccm.150.4.7921453","article-title":"Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part two","volume":"150","author":"MacNee","year":"1994","journal-title":"Am J Resp Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2020.09.258_bib36","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1165\/rcmb.2006-0379TR","article-title":"The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis","volume":"37","author":"Konigshoff","year":"2007","journal-title":"Am J Resp Cell Mol Biol"},{"issue":"13","key":"10.1016\/j.chest.2020.09.258_bib37","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/CIRCULATIONAHA.115.020207","article-title":"Association of borderline pulmonary hypertension with mortality and hospitalization in a large patient cohort: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program","volume":"133","author":"Maron","year":"2016","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.chest.2020.09.258_bib38","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.amjcard.2014.08.045","article-title":"A\u00a0national clinical quality program for Veterans Affairs catheterization laboratories (from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program)","volume":"114","author":"Maddox","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.chest.2020.09.258_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1478-7954-4-2","article-title":"Accuracy and completeness of mortality data in the Department of Veterans Affairs","volume":"4","author":"Sohn","year":"2006","journal-title":"Popul Health Metr"},{"issue":"12","key":"10.1016\/j.chest.2020.09.258_bib40","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1164\/rccm.201801-0048LE","article-title":"H2-receptor antagonist use and mortality in pulmonary hypertension: insight from the VA-CART program","volume":"197","author":"Leary","year":"2018","journal-title":"Am J Resp Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2020.09.258_bib41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2020.09.258_bib42","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0735-1097(87)80459-X","article-title":"Right ventricular dysfunction and the exercise limitation of chronic obstructive pulmonary disease","volume":"9","author":"Morrison","year":"1987","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.chest.2020.09.258_bib43","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1378\/chest.109.2.380","article-title":"Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients","volume":"109","author":"Chaouat","year":"1996","journal-title":"Chest"},{"issue":"25","key":"10.1016\/j.chest.2020.09.258_bib44","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1161\/CIRCULATIONAHA.113.008461","article-title":"Right ventricular function in heart failure with preserved ejection fraction: a community-based study","volume":"130","author":"Mohammed","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.chest.2020.09.258_bib45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.chest.2020.09.258_bib46","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.109.192666","article-title":"Executive summary: heart disease and stroke statistics\u20142010 update: a report from the American Heart Association","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.chest.2020.09.258_bib47","first-page":"1","article-title":"Pulmonary hypertension surveillance\u2014United States, 1980-2002","volume":"54","author":"Hyduk","year":"2005","journal-title":"MMWR Surveill Summ"},{"issue":"5","key":"10.1016\/j.chest.2020.09.258_bib48","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCHEARTFAILURE.112.000091","article-title":"Clinical profile and underdiagnosis of pulmonary hypertension in US veteran patients","volume":"6","author":"Maron","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"10","key":"10.1016\/j.chest.2020.09.258_bib49","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s11606-018-4433-7","article-title":"Comparing quality of care in Veterans Affairs and non-Veterans Affairs settings","volume":"33","author":"Anhang Price","year":"2018","journal-title":"J\u00a0Gen Intern Med"},{"issue":"17","key":"10.1016\/j.chest.2020.09.258_bib50","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1001\/jama.2018.12288","article-title":"Evaluation of lowering the P value threshold for statistical significance from .05 to .005 in previously published randomized clinical trials in major medical journals","volume":"320","author":"Wayant","year":"2018","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.chest.2020.09.258_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187734","article-title":"Sex-based differences in veterans with pulmonary hypertension: results from the veterans affairs-clinical assessment reporting and tracking database","volume":"12","author":"Ventetuolo","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.chest.2020.09.258_bib52","doi-asserted-by":"crossref","DOI":"10.1177\/2045894019868422","article-title":"Rates of hospitalization associated with the use of aldosterone receptor antagonists in patients with pulmonary arterial hypertension","volume":"9","author":"Corkish ME","year":"2019","journal-title":"Pulm Circ"},{"issue":"4","key":"10.1016\/j.chest.2020.09.258_bib53","first-page":"335","article-title":"Confounding by indication","volume":"7","author":"Walker","year":"1996","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.chest.2020.09.258_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10654-014-9899-y","article-title":"All-cause mortality as an outcome in epidemiologic studies: proceed with caution","volume":"29","author":"Weiss","year":"2014","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.chest.2020.09.258_bib55","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jchf.2019.01.003","article-title":"Sex differences in outcomes and responses to spironolactone in heart failure with preserved ejection fraction: a secondary analysis of TOPCAT Trial","volume":"7","author":"Merrill","year":"2019","journal-title":"JACC Heart Fail"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220348510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220348510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:59:34Z","timestamp":1762124374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369220348510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0012369220348510"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2020.09.258","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renin-Angiotensin-Aldosterone System Inhibitor Use and Mortality in Pulmonary Hypertension","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2020.09.258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}